Screening mammography: sparing the emperor's blushes
- PMID: 27683022
- PMCID: PMC5083754
- DOI: 10.1002/cam4.859
Screening mammography: sparing the emperor's blushes
Abstract
Differing interpretations about evidence on benefits and harms of screening mammography has led to conflicting recommendations among different jurisdictions that range from intensive screening starting at age 40 to no screening at all. Despite broad attention of scientific and nonscientific media, evidence suggests substantial discrepancy between real and perceived benefits of screening mammography among women. In this commentary, underlying concept of mammographic screening, limitations in primary evidence, results from secondary evidence, and existing misunderstandings are underscored with a critical gaze at available information.
Keywords: Breast cancer; mammography; overdiagnosis; overtreatment; screening.
© 2016 The Authors. Cancer Medicine published by John Wiley & Sons Ltd.
References
-
- Biller‐Andorno, N. , and Juni P.. 2014. Abolishing mammography screening programs? A view from the Swiss Medical Board. N. Engl. J. Med. 370:1965–1967. - PubMed
-
- Welch, H. G. , Gorski D. H., and Albertsen P. C.. 2015. Trends in metastatic breast and prostate cancer‐lessons in cancer dynamics. N. Engl. J. Med. 373:1685–1687. - PubMed
-
- Kalager, M. , Adami H. O., Bretthauer M., et al. 2012. Overdiagnosis of invasive breast cancer due to mammography screening: results from the Norwegian screening program. Ann. Intern. Med. 156:491–499. - PubMed
-
- Bleyer, A. , and Welch H. G.. 2012. Effect of three decades of screening mammography on breast‐cancer incidence. N. Engl. J. Med. 367:1998–2005. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
